Propanc Biopharma, Inc. Common Stock (PPCB)

Propanc Biopharma, Inc. Common Stock (PPCB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.8M; returns 1 day +2.2%, 1 week -18.1%, 1 year -99.2%.

Propanc Biopharma, Inc. (PPCB) is a clinical-stage biopharmaceutical company headquartered in Australia, specializing in the development of proenzyme-based oncology treatments.

Groups PPCB belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Biotechnology
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage Biopharma
• Life Sciences
• Drug Discovery
• Healthcare Innovation
• R&D

PPCB financial model: income statement, cash flow and balance sheet